Infliximab (Anti-TNF-alpha) (Avakine (Anti-TNF-alpha)) is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-alpha. Infliximab (Anti-TNF-alpha) prevents the interaction of TNF-alpha with TNF-alpha receptor (TNFR1 and TNFR2). Infliximab (Anti-TNF-alpha) has the potential for autoimmune, chronic inflammatory diseases and diabetic neuropathy research[1][2].
Molecular Weight:
(145.886 kDa)
Purity:
99.00
Target:
TNF Receptor
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted